Heart 1998;79:576-581 ( June )

Fetal tachycardias: management and outcome of 127 consecutive cases

J M Simpson, G K Sharland

Department of Fetal Cardiology, 15th Floor, Guy's Hospital, London SE1 9RT, UK

Correspondence to: Dr Simpson.

Accepted for publication 3 February 1998

ObjectiveTo review the management and outcome of fetal tachycardia, and to determine the problems encountered with various treatment protocols.
Study designRetrospective analysis.
Subjects127 consecutive fetuses with a tachycardia presenting between 1980 and 1996 to a single tertiary centre for fetal cardiology. The median gestational age at presentation was 32 weeks (range 18 to 42).
Results105 fetuses had a supraventricular tachycardia and 22 had atrial flutter. Overall, 52 fetuses were hydropic and 75 non-hydropic. Prenatal control of the tachycardia was achieved in 83% of treated non-hydropic fetuses compared with 66% of the treated hydropic fetuses. Digoxin monotherapy converted most (62%) of the treated non-hydropic fetuses, and 96% survived through the neonatal period. First line drug treatment for hydropic fetuses was more diverse, including digoxin (n = 5), digoxin plus verapamil (n = 14), and flecainide (n = 27). The response rates to these drugs were 20%, 57%, and 59%, respectively, confirming that digoxin monotherapy is a poor choice for the hydropic fetus. Response to flecainide was faster than to the other drugs. Direct fetal treatment was used in four fetuses, of whom two survived. Overall, 73% (n = 38) of the hydropic fetuses survived. Postnatally, 4% of the non-hydropic group had ECG evidence of pre-excitation, compared with 16% of the hydropic group; 57% of non-hydropic fetuses were treated with long term antiarrhythmics compared with 79% of hydropic fetuses.
ConclusionsNon-hydropic fetuses with tachycardias have a very good prognosis with transplacental treatment. Most arrhythmias associated with fetal hydrops can be controlled with transplacental treatment, but the mortality in this group is 27%. At present, there is no ideal treatment protocol for these fetuses and a large prospective multicentre trial is required to optimise treatment of both hydropic and non-hydropic fetuses.

Keywords: fetal tachycardia;  atrial flutter;  supraventricular tachycardia

---

© 1998 by Heart
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Hahurij, N. D., Gittenberger-De Groot, A. C., Kolditz, D. P., Bokenkamp, R., Schalij, M. J., Poelmann, R. E., Blom, N. A. (2008). Accessory Atrioventricular Myocardial Connections in the Developing Human Heart: Relevance for Perinatal Supraventricular Tachycardias. Circulation 117: 2850-2858 [Abstract] [Full Text]  
• Killen, S. A.S., Fish, F. A. (2008). Fetal and Neonatal Arrhythmias. NeoReviews 9: e242-e252 [Abstract] [Full Text]  
• Hornberger, L. K, Sahn, D. J (2007). Rhythm abnormalities of the fetus. Heart 93: 1294-1300 [Full Text]  
• Garland, M., Abildskov, K. M., Taylor, S., Benzeroual, K., Caspersen, C. S., Arroyo, S. E., Kiu, T.-w., Reznik, B., Weldy, P., Daniel, S. S., Stark, R. I. (2006). FETAL MORPHINE METABOLISM AND CLEARANCE ARE CONSTANT DURING LATE GESTATION. Drug Metab. Dispos. 34: 636-646 [Abstract] [Full Text]  
• Singh, H. R., Garekar, S., Epstein, M. L., L'Ecuyer, T. (2005). Neonatal Supraventricular Tachycardia (SVT). NeoReviews 6: e339-e350 [Full Text]  
• Schmidt, M. R., Kristiansen, S. B., White, P., Smerup, M., Botker, H. E., Vogel, M., Hjortdal, V., Sorensen, K., Redington, A. (2004). Glucose-insulin infusion improves cardiac function during fetal tachycardia. J Am Coll Cardiol 43: 445-452 [Abstract] [Full Text]  
• Strasburger, J. F., Cuneo, B. F., Michon, M. M., Gotteiner, N. L., Deal, B. J., McGregor, S. N., Oudijk, M. A., Meijboom, E. J., Feinkind, L., Hussey, M., Parilla, B. V. (2004). Amiodarone Therapy for Drug-Refractory Fetal Tachycardia. Circulation 109: 375-379 [Abstract] [Full Text]  
• Committee Members, , Blomstrom-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., Campbell, W. B., Haines, D. E., Kuck, K. H., Lerman, B. B., Miller, D. D., Shaeffer, C. W. Jr, Stevenson, W. G., Tomaselli, G. F., Task Force Members, , Antman, E. M., Smith, S. C. Jr, Alpert, J. S., Faxon, D. P., Fuster, V., Gibbons, R. J., Gregoratos, G., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Russell, R. O. Jr, ESC Committee for Practice Guidelines Members, , Priori, S. G., Blanc, J.-J., Budaj, A., Burgos, E. F., Cowie, M., Deckers, J. W., Garcia, M. A. A., Klein, W. W., Lekakis, J., Lindahl, B., Mazzotta, G., Morais, J. C. A., Oto, A., Smiseth, O., Trappe, H.-J. (2003). ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias --executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol 42: 1493-1531 [Full Text]  
• Blomstrom-Lundqvist, C., Scheinman, M. M., Aliot, E. M., Alpert, J. S., Calkins, H., Camm, A. J., Campbell, W. B., Haines, D. E., Kuck, K. H., Lerman, B. B., Miller, D. D., Shaeffer, C. W. Jr, Stevenson, W. G., Tomaselli, G. F., Antman, E. M., Smith, S. C. Jr, Alpert, J. S., Faxon, D. P., Fuster, V., Gibbons, R. J., Gregoratos, G., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Russell, R. O. Jr, Priori, S. G., Blanc, J.-J., Budaj, A., Burgos, E. F., Cowie, M., Deckers, J. W., Garcia, M. A. A., Klein, W. W., Lekakis, J., Lindahl, B., Mazzotta, G., Morais, J. C. A., Oto, A., Smiseth, O., Trappe, H.-J., Committee Members, , Task Force Members, , ESC Committee for Practice Guidelines Members, (2003). ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias*--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 108: 1871-1909 [Full Text]  
• Committee Members, , Blomstrom-Lundqvist, C., Scheinman, M. M, Aliot, E. M, Alpert, J. S, Calkins, H., Camm, A.J., Campbell, W.B., Haines, D. E, Kuck, K. H, Lerman, B. B, Miller, D.D., Shaeffer, C. W. Jr, Stevenson, W. G, Tomaselli, G. F, Task Force Members, , Antman, E. M, Smith, S. C Jr, Alpert, J. S, Faxon, D. P, Fuster, V., Gibbons, R. J, Gregoratos, G., Hiratzka, L. F, Hunt, S. A., Jacobs, A. K, Russell, R. O Jr, ESC Committee for Practice Guidelines Members, , Priori, S. G, Blanc, J.-J., Budaj, A., Burgos, E. F., Cowie, M., Deckers, J. W., Garcia, M. A. A., Klein, W. W, Lekakis, J., Lindahl, B., Mazzotta, G., Morais, J. C. A., Oto, A., Smiseth, O., Trappe, H.-J. (2003). ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: A Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)Developed in collaboration with NASPE-Heart Rhythm Society. Eur Heart J 24: 1857-1897 [Full Text]  
• Hall, C. M, Platt, M. P W. (2003). Neonatal flecainide toxicity following supraventricular tachycardia treatment. The Annals of Pharmacotherapy 37: 1343-1344 [Full Text]  
• Oudijk, M. A., Ruskamp, J. M., Ververs, F. F. T., Ambachtsheer, E. B., Stoutenbeek, P., Visser, G. H. A., Meijboom, E. J. (2003). Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics. J Am Coll Cardiol 42: 765-770 [Abstract] [Full Text]  
• Krapp, M, Kohl, T, Simpson, J M, Sharland, G K, Katalinic, A, Gembruch, U (2003). Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89: 913-917 [Abstract] [Full Text]  
• Tan, H.L., Lie, K.I. (2001). Treatment of tachyarrhythmias during pregnancy and lactation. Eur Heart J 22: 458-464  
• Oudijk, M. A., Michon, M. M., Kleinman, C. S., Kapusta, L., Stoutenbeek, P., Visser, G. H. A., Meijboom, E. J. (2000). Sotalol in the Treatment of Fetal Dysrhythmias. Circulation 101: 2721-2726 [Abstract] [Full Text]  
• Kohl, T., Kirchhof, P. F., Gogarten, W., Reckers, J., Asfour, B., Witteler, R., Haverkamp, W., Eckardt, L., Marcus, A. E., VanAken, H., Breithardt, G., Vogt, J., Scheld, H. H. (1999). Fetoscopic Transesophageal Electrocardiography and Stimulation in Fetal Sheep : A Minimally Invasive Approach Aimed at Diagnosis and Termination of Therapy-Refractory Supraventricular Tachycardias in Human Fetuses. Circulation 100: 772-776 [Abstract] [Full Text]